Clinical Trials in San Antonio

Showing 2841-2860 of 7,028 trials

Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects

NCT04643795

The purpose of this study is to directly characterize the pharmacokinetic (PK) profiles of MGL-3196 and its major metabolite (MGL-3623) following administration of multiple oral doses (QD x 6 days) in subjects with varying degrees of hepatic impairment (HI) compared to healthy matched control subjects with normal hepatic function, including a subset of NASH subjects.

Hepatic ImpairmentNASH - Nonalcoholic SteatohepatitisCirrhosis, Liver

Madrigal Pharmaceuticals, Inc.87 participantsStarted Oct 2018

Orlando, Florida, United States • Saint Paul, Minnesota, United States • San Antonio, Texas, United States

COMPLETEDPhase 1/2< 1 mile

A Study to Evaluate TRS01 Eye Drops in Participants With Active Non-infectious Anterior Uveitis

NCT04222712

The objective of this study is to evaluate the safety of TRS01 eye drops in participants with active non-infectious anterior uveitis .

Non-infectious Anterior Uveitis

Tarsier Pharma16 participantsStarted Feb 2020

Palisades Park, New Jersey, United States • San Antonio, Texas, United States

COMPLETEDPhase 2< 1 mile

A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients

NCT05035641

This is a pilot phase II study to evaluate the safety and efficacy of AND017 in NDD-CKD patients

Renal Anemia

Kind Pharmaceuticals LLC113 participantsStarted Oct 2021

Northridge, California, United States • Winter Park, Florida, United States • Shreveport, Louisiana, United States +5 more locations

Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects

A Study to Evaluate TRS01 Eye Drops in Participants With Active Non-infectious Anterior Uveitis

A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients

Find Trials by Condition in San Antonio

Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis

Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C"

Safety Study of Femoral Neck Fracture System

Cardiovascular Safety Study of Tipifarnib in Patients With Advanced Solid Malignancies

Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors

Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.

Base-in Prism Spectacles for Intermittent Exotropia

Timing of Inguinal Hernia Repair in Premature Infants

MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.

Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes

A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide

Development of the Virtual Unified Huntington's Disease Rating Scale

Bioaerosol Sampling Device (BSD) Clinical Study

Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-Small Cell Lung Cancer (NSCLC) (MK-3475-598/KEYNOTE-598)

Addressing Intimate Partner Violence Among Women Veterans

A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Negative for Hepatitis B e Antigen